• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      Will a Sunburn Turn Into a Tan? - 4 hour(s) ago

      Can a sunburn just fade into a savage tan? The answer is maybe — but that doesn’t mean your skin avoided damage.

      Source: health.clevelandclinic.org
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	ClevelandClinic
        ClevelandClinic

        You can’t completely avoid UV rays, but you can take steps to minimize exposure, prevent sunburns and tans, and lower your skin cancer risk. It starts with applying sunscreen every day. https://t.co/3CNGCgHqem

    • Mashup Score: 27
      Meaningful engagement with people with lived experience: challenging, messy, and more vital than ever - 5 hour(s) ago

      Health and care leaders and policy makers at every level should urgently implement WHO’s recent framework on engagement, write Maia Olsen, Katia de Pinho Campos, and Guy Fones Recognition that people with lived experience of disease should be equal partners in decision making about health policy and research and healthcare practice has been limited until recent years. The World Health Organization’s 2023 framework on meaningful engagement of people living with non-communicable diseases (NCDs) and mental health and neurological conditions takes steps to address the gap, explicitly calling for equitable inclusion that transfers power to people with lived experience, and for their experience to be valued as expertise.1 Meaningful engagement in policy and programme development is often viewed as a “nice to have”; however, it is essential for equitable, person centred, and rights based responses to improving health outcomes. The BMJ Collection on Lived Experience as Expertise (https://www.b

      Source: www.bmj.com
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	bmj_latest
        bmj_latest

        Meaningful engagement with people with lived experience: challenging, messy, and more vital than ever. Healthcare leaders at every level must urgently implement @WHO framework on engagement, writes @maiacaryn https://t.co/7rXl4E4VTh

    • Mashup Score: 11
      Implementation of a novel point-of-care technology: the Genedrive MT-RNR1 test - 17 hour(s) ago

      Quality improvement project implementing the Genedrive MT-RNR1 point-of-care technology into a neonatal intensive care unit (NICU). Gentamicin is a commonly used aminoglycoside antibiotic. The National Institute for Health and Care Excellence (NICE) guidelines recommend gentamicin and benzylpenicillin for first-line treatment of neonatal early-onset sepsis.1 However, individuals carrying the m.1555A>G genetic variant on the MT-RNR1 mitochondrial gene are at higher risk of developing irreversible deafness, if given even a single dose of aminoglycoside.2 3 The prevalence of the variant in the general population is 1 in 500.3 Despite the risks, gentamicin (with benzylpenicillin) continues to be used due to its effectiveness and narrow spectrum of antibiotic cover, contributing to a lower risk of antibiotic resistance.1 It is also recommended that antibiotics should be delivered within 1 hour of identifying or suspecting sepsis.1 A new point-of-care test, called the Genedrive MT-RNR1 ID Ki

      Source: ep.bmj.com
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	ADC_BMJ
        ADC_BMJ

        1 in 500 neonates carry genetic variant that is associated with deafness with gentamicin antibiotics Using QI to implement a novel point-of-care technology to detect MT-RNR1 https://t.co/kI4ED5VNL0 https://t.co/1mW8eBkHSK

    • Mashup Score: 1
      Radiation or Immune-Modulating Drugs Could Mitigate Resistance to CDK4/6 Inhibitors in Breast Cancer - 21 hour(s) ago

      Research reveals that combining radiotherapy or immune-modulating drugs with CDK4/6 inhibitors enhances treatment efficacy in HR+/HER2– breast cancer.

      Source: www.pharmacytimes.com
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	Pharmacy_Times
        Pharmacy_Times

        Combining radiotherapy or immune-modulating drugs with CDK4/6 inhibitors may counteract the immunosuppressive tumor microenvironment in HR+/HER2– breast cancer and improve treatment response. Read more: https://t.co/TZC2yN0LbI https://t.co/yu6Ub7yutm

    • Mashup Score: 3
      Recipe: Shortcakes With Orange-Infused Strawberries and Whipped Cream - 21 hour(s) ago

      Sugar substitutes and fresh fruits come together for this lightened-up dessert.

      Source: health.clevelandclinic.org
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	ClevelandClinic
        ClevelandClinic

        This recipe demonstrates how simple ingredient substitutions can result in mouthwatering masterpieces that will fool even the biggest healthy dessert skeptics. https://t.co/y0c1DLwacs

    • Mashup Score: 0
      Optimizing RSV Vaccination: The Pharmacist’s Role in Patient Care - 1 day(s) ago

      A panelist discusses how pharmacists must be equipped with essential clinical knowledge, communication skills, and up-to-date information to administer RSV vaccines effectively, optimize vaccine uptake through patient education and hesitancy management, and respond appropriately to adverse events.

      Source: www.pharmacytimes.com
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	Pharmacy_Times
        Pharmacy_Times

        View the episodes here: https://t.co/p9v3ECxJ2Z

    • Mashup Score: 1
      Biophysics | bioRxiv - 1 day(s) ago

      bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution

      Source: www.biorxiv.org
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	biorxivpreprint
        biorxivpreprint

        New papers posted on August 14, 2024: 3 in biophysics: https://t.co/WExV4x2xPK 1 in cancer biology: https://t.co/7DXtDVhlLd 6 in cell biology: https://t.co/vO1EPg76bW 2 in evolutionary biology: https://t.co/0k6EOYGNAt 1 in genetics: https://t.co/dzLSXauFuh

    • Mashup Score: 8
      Five physician specialties that spend the most time in the EHR - 1 day(s) ago

      A new study compares EHR time demands among specialties, as well as which physicians are required to do the most work after hours.

      Source: www.ama-assn.org
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	AmerMedicalAssn
        AmerMedicalAssn

        Deep dive on physician burnout and professional satisfaction: 🔴 5 specialties that spend the most time in the EHR - https://t.co/meBE820Mci 🟡 Which physician specialties are seeing a drop in burnout? - https://t.co/zYNHMruabG 🟢 How this physician is burnout-free after 50

    • Mashup Score: 0
      Can AI and tech help streamline prior auths? What you need to know - 2 day(s) ago

      Prior authorizations are a major burden for practices. How can AI and other technology help physicians in the fight?

      Source: www.medicaleconomics.com
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	MedEconomics
        MedEconomics

        Prior auths = major headache. AI = possible relief. 🤖 Brad Boyd of @BDO_USA breaks down how tech could streamline approvals and reduce admin burden. 🎥 Watch the full interview: https://t.co/Z7jLzL9NaA

    • Mashup Score: 0
      Steroid Use During ICI Treatment Lessens Effectiveness in Patients With NSCLC - 2 day(s) ago

      Steroids hindered the shrinkage of tumors in patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitor (ICI) therapy.

      Source: www.pharmacytimes.com
      Categories: General Medicine News, General Journals & Societ
      Tweet Tweets with this article
      • Profile photo of 	Pharmacy_Times
        Pharmacy_Times

        Read more: https://t.co/XtKhQSXRHF

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings